Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
Multi-center clinical trial includes sites located in the US, UK and EU…
MediBeacon Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
Consensus concludes sold-out debut event in Hong Kong and announces return to Asia in 2026
The Hong Kong Convention and Exhibition Centre reached maximum capacity, with nearly…
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
BOSTON--(BUSINESS WIRE)--The Eaton Vance closed-end funds listed below released today the estimated…
Guangdong’s GDP estimated to surpass 14 trillion yuan in 2024
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- In accordance with the government…
Guangdong’s GDP estimated to surpass 14 trillion yuan in 2024
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- In accordance with the government…
Guangdong’s GDP estimated to surpass 14 trillion yuan in 2024
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- In accordance with the government…
Guangdong’s GDP estimated to surpass 14 trillion yuan in 2024
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- In accordance with the government…
Guangdong’s GDP estimated to surpass 14 trillion yuan in 2024
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- In accordance with the government…
Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth
EXOSENS ANNOUNCES 2024 ESTIMATED RESULTS ABOVE IPO GUIDANCE; 2025 GUIDANCE HIGHLIGHTING LOW…